1,242 Shares in Johnson & Johnson (NYSE:JNJ) Bought by New England Professional Planning Group Inc.

Posted by Defense World Staff on Mar 24th, 2023

New England Professional Planning Group Inc. purchased a new position in shares of Johnson & Johnson (NYSE:JNJ – Get Rating) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 1,242 shares of the company’s stock, valued at approximately $219,000.

A number of other large investors also recently modified their holdings of JNJ. Glassy Mountain Advisors Inc. acquired a new stake in Johnson & Johnson in the fourth quarter valued at $35,000. TD Capital Management LLC acquired a new stake in Johnson & Johnson in the 3rd quarter valued at about $48,000. Piershale Financial Group Inc. acquired a new position in Johnson & Johnson during the fourth quarter worth approximately $61,000. Cowa LLC bought a new stake in Johnson & Johnson in the third quarter valued at approximately $58,000. Finally, Legend Financial Advisors Inc. acquired a new stake in shares of Johnson & Johnson in the third quarter valued at approximately $59,000. 67.94% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several equities research analysts have issued reports on JNJ shares. Citigroup raised their price target on Johnson & Johnson from $198.00 to $205.00 and gave the company a “buy” rating in a report on Monday, December 12th. SVB Leerink lowered their price target on shares of Johnson & Johnson from $194.00 to $186.00 and set an “outperform” rating on the stock in a report on Friday, January 20th. Atlantic Securities boosted their price objective on Johnson & Johnson from $160.00 to $168.00 and gave the stock a “neutral” rating in a report on Wednesday, January 25th. StockNews.com started coverage on Johnson & Johnson in a research note on Thursday, March 16th. They set a “strong-buy” rating on the stock. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $215.00 price objective on shares of Johnson & Johnson in a report on Wednesday, February 1st. Seven analysts have rated the stock with a hold rating, six have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, Johnson & Johnson has a consensus rating of “Moderate Buy” and an average price target of $174.73.

Insider Buying and Selling at Johnson & Johnson

In other news, insider James D. Swanson sold 1,062 shares of the stock in a transaction on Monday, March 6th. The stock was sold at an average price of $154.66, for a total value of $164,248.92. Following the completion of the transaction, the insider now directly owns 9,215 shares in the company, valued at approximately $1,425,191.90. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 0.35% of the company’s stock.

Johnson & Johnson Stock Up 0.1 %

Shares of JNJ opened at $151.13 on Friday. The firm has a 50 day simple moving average of $160.17 and a two-hundred day simple moving average of $167.59. The company has a debt-to-equity ratio of 0.35, a current ratio of 0.99 and a quick ratio of 0.77. Johnson & Johnson has a one year low of $150.11 and a one year high of $186.69. The company has a market cap of $393.59 billion, a P/E ratio of 22.42, a P/E/G ratio of 2.65 and a beta of 0.54.

Johnson & Johnson (NYSE:JNJ – Get Rating) last posted its quarterly earnings results on Tuesday, January 24th. The company reported $2.35 EPS for the quarter, topping analysts’ consensus estimates of $2.22 by $0.13. Johnson & Johnson had a return on equity of 35.76% and a net margin of 18.90%. The company had revenue of $23.71 billion during the quarter, compared to analysts’ expectations of $23.90 billion. During the same quarter in the previous year, the firm earned $2.13 EPS. Johnson & Johnson’s revenue was down 4.4% on a year-over-year basis. Research analysts forecast that Johnson & Johnson will post 10.5 EPS for the current fiscal year.

Johnson & Johnson Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 7th. Investors of record on Tuesday, February 21st were paid a $1.13 dividend. This represents a $4.52 annualized dividend and a yield of 2.99%. The ex-dividend date of this dividend was Friday, February 17th. Johnson & Johnson’s payout ratio is 67.06%.

About Johnson & Johnson

(Get Rating)

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer Health, Pharmaceutical, and MedTech. The Consumer Health segment includes products focused on personal healthcare used in the Skin Health/Beauty, Over-the-Counter medicines, Baby Care, Oral Care, Women’s Health and Wound Care markets.